During 2019, the company faced rapid technological development, particularly with respect to computing, automation, artificial intelligence, mobile connectivity, communications, and digitization, which are critical to its operations. The company is making significant investments, both organically and through acquisitions, to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development, and customer-facing resources. The company’s long-term growth and profitability will depend on its ability to expand its business in high-growth geographies and market segments, develop innovative and differentiated new products and services, and improve the effectiveness of its sales force. The company’s operations are affected by worldwide, regional, and industry-specific economic and political factors, and it continuously monitors key competitors and customers to gauge relative performance and future outlook. The company’s investments in technology resources and capabilities are aimed at enhancing operational efficiency and supporting business strategies. The company’s life sciences segment offers a broad range of research tools and technologies that support the research, discovery, process development, and manufacturing workflows of biopharmaceutical drugs, which underscores the importance of mobilizing and deploying IT-based resources. The company’s diagnostics segment provides analytical instruments, reagents, consumables, software, and services that are essential for diagnosing diseases and making treatment decisions, further emphasizing the integration of technology capabilities into its core operations. The company’s strategic objectives include improving the effectiveness of its sales force and continuing to reduce costs while enhancing quality, which are critical components of its operational flexibility and market responsiveness. The company’s digital transformation initiatives are focused on leveraging technology functionalities to create actionable investments that align with changing business needs and directions. The company’s governance practices ensure that its IT capabilities are effectively integrated into its overall business strategy, enabling it to respond to market dynamics and external influences. The company’s investments in IT infrastructure and systems are designed to facilitate communication and enhance relational capacity, which are vital for maintaining competitive advantage and improving firm performance. The company’s approach to resource allocation and management emphasizes the importance of strategic resource deployment in achieving business value and operational excellence. The company’s ongoing commitment to innovation partnerships and technology management is essential for navigating the challenges presented by an increasingly regulated global environment. The company’s focus on process optimization and business process management reflects its dedication to enhancing organizational effectiveness and agility in a rapidly evolving market landscape. The company’s ability to leverage its IT capabilities will play a crucial role in driving performance gains and achieving its strategic objectives, ultimately contributing to its long-term success in the competitive landscape.